Role of artificial intelligence-powered conversational agents (chatbots) in musculoskeletal disorders: a scoping review protocol.

Journal: BMJ open
PMID: 40132840

Abstract

INTRODUCTION: Musculoskeletal disorders (MSDs) represent a significant global health burden that leads to substantial disability with socioeconomic impact. With the rise of artificial intelligence (AI), particularly large language model-driven conversational agents (chatbots), there is potential to enhance the management of MSDs. However, the application of AI-powered chatbots in this population has not been comprehensively synthesised. Therefore, this scoping review aims to explore the current and potential use of AI-powered chatbots in managing MSDs. The review will map out the targeted diseases, the purposes of chatbot interventions, the clinical tools or frameworks used in training these systems and the evaluated outcomes in clinical settings.

Authors

  • Joaquin Gonzalez Aroca
    Universidad de La Serena, La Serena, Chile joaquin.gonzalez@userena.cl.
  • Laura Vergara-Merino
    Department of Traumatology and Orthopedics, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Camila Micaela Escobar Liquitay
    Research Department, Instituto Universitario Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
  • Humberto Farias
    Institute for Multidisciplinary Research, Universidad de La Serena, La Serena 8380453, Chile.
  • Jorge Olivares Arancibia
    Universidad de Las Americas, Santiago, Chile.
  • Álvaro Puelles
    Universidad de La Serena, La Serena, Chile.
  • Eva Madrid
    Escuela de Medicina, Universidad de Valparaiso, Valparaiso, Chile.

Keywords

External Resources

Popular Topics
Recent Journals